• info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) +1-214-377-1121 (US)
  • Sign In
  • Register

OtherGlobal Asthma and COPD Drug Market Insights, Forecast to 2025

  • RnM2315946
  • |
  • 8 August, 2018
  • |
  • Global
  • |
  • 98 pages
  • |
  • QYResearch
  • |
  • Other

This report studies the global market size of Asthma and COPD Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Asthma and COPD Drug in these regions.
This research report categorizes the global Asthma and COPD Drug market by top players/brands, region, type and end user. This report also studies the global Asthma and COPD Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

Asthma and chronic obstructive pulmonary disease (Asthma/COPD) are a common type of chronic disease. Once they are sick, they usually need long-term medication, which seriously affects people's quality of life.
The 2016 Global Asthma Prevention Initiative (GINA) organization has re-released its Consensus on Asthma, COPD and Asthma-COPD Overlap Syndrome, developed in collaboration with the Global Scientific Committee on Chronic Obstructive Pulmonary Disease Prevention (GOLD). A method of identifying such patients is provided.
The global Asthma and COPD Drug market is valued at 5200 million US$ in 2017 and will reach 8040 million US$ by the end of 2025, growing at a CAGR of 5.6% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Asthma and COPD Drug market based on company, product type, end user and key regions.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Boehringer Ingelheim
GlaxoSmithKline
Merck and Co
Novartis AG
AstraZeneca
F. Hoffmann-La Roche

Market size by Product
Bronchodilators
Anti-inflammatory Drugs
Monoclonal Antibodies
Combination Drugs
Market size by End User
Asthma
COPD

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Asthma and COPD Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Asthma and COPD Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Asthma and COPD Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Asthma and COPD Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Asthma and COPD Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Asthma and COPD Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

1 Study Coverage
1.1 Asthma and COPD Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Asthma and COPD Drug Market Size Growth Rate by Product
1.4.2 Bronchodilators
1.4.3 Anti-inflammatory Drugs
1.4.4 Monoclonal Antibodies
1.4.5 Combination Drugs
1.5 Market by End User
1.5.1 Global Asthma and COPD Drug Market Size Growth Rate by End User
1.5.2 Asthma
1.5.3 COPD
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Asthma and COPD Drug Market Size
2.1.1 Global Asthma and COPD Drug Revenue 2013-2025
2.1.2 Global Asthma and COPD Drug Sales 2013-2025
2.2 Asthma and COPD Drug Growth Rate by Regions
2.2.1 Global Asthma and COPD Drug Sales by Regions
2.2.2 Global Asthma and COPD Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Asthma and COPD Drug Sales by Manufacturers
3.1.1 Asthma and COPD Drug Sales by Manufacturers
3.1.2 Asthma and COPD Drug Sales Market Share by Manufacturers
3.1.3 Global Asthma and COPD Drug Market Concentration Ratio (CR5 and HHI)
3.2 Asthma and COPD Drug Revenue by Manufacturers
3.2.1 Asthma and COPD Drug Revenue by Manufacturers (2013-2018)
3.2.2 Asthma and COPD Drug Revenue Share by Manufacturers (2013-2018)
3.3 Asthma and COPD Drug Price by Manufacturers
3.4 Asthma and COPD Drug Manufacturing Base Distribution, Product Types
3.4.1 Asthma and COPD Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Asthma and COPD Drug Product Type
3.4.3 Date of International Manufacturers Enter into Asthma and COPD Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Asthma and COPD Drug Sales by Product
4.2 Global Asthma and COPD Drug Revenue by Product
4.3 Asthma and COPD Drug Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Asthma and COPD Drug Breakdown Data by End User

6 North America
6.1 North America Asthma and COPD Drug by Countries
6.1.1 North America Asthma and COPD Drug Sales by Countries
6.1.2 North America Asthma and COPD Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Asthma and COPD Drug by Product
6.3 North America Asthma and COPD Drug by End User

7 Europe
7.1 Europe Asthma and COPD Drug by Countries
7.1.1 Europe Asthma and COPD Drug Sales by Countries
7.1.2 Europe Asthma and COPD Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Asthma and COPD Drug by Product
7.3 Europe Asthma and COPD Drug by End User

8 Asia Pacific
8.1 Asia Pacific Asthma and COPD Drug by Countries
8.1.1 Asia Pacific Asthma and COPD Drug Sales by Countries
8.1.2 Asia Pacific Asthma and COPD Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Asthma and COPD Drug by Product
8.3 Asia Pacific Asthma and COPD Drug by End User

9 Central & South America
9.1 Central & South America Asthma and COPD Drug by Countries
9.1.1 Central & South America Asthma and COPD Drug Sales by Countries
9.1.2 Central & South America Asthma and COPD Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Asthma and COPD Drug by Product
9.3 Central & South America Asthma and COPD Drug by End User

10 Middle East and Africa
10.1 Middle East and Africa Asthma and COPD Drug by Countries
10.1.1 Middle East and Africa Asthma and COPD Drug Sales by Countries
10.1.2 Middle East and Africa Asthma and COPD Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Asthma and COPD Drug by Product
10.3 Middle East and Africa Asthma and COPD Drug by End User

11 Company Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Company Business Overview
11.1.3 Boehringer Ingelheim Asthma and COPD Drug Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Boehringer Ingelheim Asthma and COPD Drug Products Offered
11.1.5 Boehringer Ingelheim Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 Company Business Overview
11.2.3 GlaxoSmithKline Asthma and COPD Drug Sales, Revenue and Gross Margin (2013-2018)
11.2.4 GlaxoSmithKline Asthma and COPD Drug Products Offered
11.2.5 GlaxoSmithKline Recent Development
11.3 Merck and Co
11.3.1 Merck and Co Company Details
11.3.2 Company Business Overview
11.3.Merck and Co Asthma and COPD Drug Sales, Revenue and Gross Margin (2013-2018)
11.3.4 Merck and Co Asthma and COPD Drug Products Offered
11.3.5 Merck and Co Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Company Business Overview
11.4.3 Novartis AG Asthma and COPD Drug Sales, Revenue and Gross Margin (2013-2018)
11.4.4 Novartis AG Asthma and COPD Drug Products Offered
11.4.5 Novartis AG Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 Company Business Overview
11.5.3 AstraZeneca Asthma and COPD Drug Sales, Revenue and Gross Margin (2013-2018)
11.5.4 AstraZeneca Asthma and COPD Drug Products Offered
11.5.5 AstraZeneca Recent Development
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Company Details
11.6.2 Company Business Overview
11.6.3 F. Hoffmann-La Roche Asthma and COPD Drug Sales, Revenue and Gross Margin (2013-2018)
11.6.4 F. Hoffmann-La Roche Asthma and COPD Drug Products Offered
11.6.5 F. Hoffmann-La Roche Recent Development

12 Future Forecast
12.1 Asthma and COPD Drug Market Forecast by Regions
12.1.1 Global Asthma and COPD Drug Sales Forecast by Regions 2018-2025
12.1.2 Global Asthma and COPD Drug Revenue Forecast by Regions 2018-2025
12.2 Asthma and COPD Drug Market Forecast by Product
12.2.1 Global Asthma and COPD Drug Sales Forecast by Product 2018-2025
12.2.2 Global Asthma and COPD Drug Revenue Forecast by Product 2018-2025
12.3 Asthma and COPD Drug Market Forecast by End User
12.4 North America Asthma and COPD Drug Forecast
12.5 Europe Asthma and COPD Drug Forecast
12.6 Asia Pacific Asthma and COPD Drug Forecast
12.7 Central & South America Asthma and COPD Drug Forecast
12.8 Middle East and Africa Asthma and COPD Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Asthma and COPD Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:



Summary:
Get latest Market Research Reports on Asthma and COPD Drug. Industry analysis & Market Report on Asthma and COPD Drug is a syndicated market report, published as Global Asthma and COPD Drug Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Asthma and COPD Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$4,900.00
$9,800.00
3,290.35
6,580.70
4,508.98
9,017.96
593,586.00
1,187,172.00
324,935.66
649,871.32
Add To Cart Credit card Logo

Related Reports


Reason to Buy